|
KIAA0562 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.89446244750025E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.73299218998136E-12 |
| Normal-vs-Stage2 |
4.98799890280566E-11 |
| Normal-vs-Stage3 |
5.21180000045973E-07 |
| Normal-vs-Stage4 |
5.99900018549704E-10 |
| Stage1-vs-Stage2 |
5.132200E-02 |
| Stage1-vs-Stage3 |
9.464600E-01 |
| Stage1-vs-Stage4 |
8.003900E-02 |
| Stage2-vs-Stage3 |
1.045780E-01 |
| Stage2-vs-Stage4 |
3.484600E-01 |
| Stage3-vs-Stage4 |
3.806200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.53441712061431E-12 |
| Normal-vs-AfricanAmerican |
1.41010003673614E-09 |
| Normal-vs-Asian |
2.10270000000623E-06 |
| Caucasian-vs-AfricanAmerican |
6.917200E-01 |
| Caucasian-vs-Asian |
3.314200E-01 |
| AfricanAmerican-vs-Asian |
4.545000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.64579461170433E-12 |
| Normal-vs-Female |
8.631800E-04 |
| Male-vs-Female |
4.679200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.8222299999926E-05 |
| Normal-vs-Extreme_Weight |
2.24265050974282E-14 |
| Normal-vs-Obese |
4.85249951331923E-10 |
| Normal-vs-Extreme_Obese |
6.376100E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.284800E-01 |
| Normal_Weight-vs-Obese |
8.968200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.935000E-01 |
| Extreme_Weight-vs-Obese |
1.219170E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.894400E-01 |
| Obese-vs-Extreme_Obese |
9.271800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.9849999995153E-07 |
| Normal-vs-Age(41-60Yrs) |
7.99470489809551E-11 |
| Normal-vs-Age(61-80Yrs) |
1.85307325040185E-12 |
| Normal-vs-Age(81-100Yrs) |
8.7289000028079E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.293200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.968800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.415200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.105400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.584800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.812400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.40443212615082E-13 |
| Normal-VS-Type2 PRCC |
1.97770000043285E-07 |
| Normal-VS-KIRP CIMP |
1.72519999996901E-06 |
| Normal-VS-Unclassified PRCC |
1.52823999999274E-05 |
| Type1 PRCC-VS-Type2 PRCC |
4.433200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.059400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.164200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.105200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.543600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.943000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.77717865265959E-12 |
| Normal-vs-N1 |
2.31190000477E-09 |
| Normal-vs-N2 |
7.82110000000502E-05 |
| N0-vs-N1 |
9.762200E-01 |
| N0-vs-N2 |
6.766400E-01 |
| N1-vs-N2 |
6.600000E-01 |
|
|
